6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis

被引:68
|
作者
Ocio, E. M.
Schop, R. F. J.
Gonzalez, B.
Van Wier, S. A.
Hernandez-Rivas, J. M.
Gutierrez, N. C.
Garcia-Sanz, R.
Moro, M. J.
Aguilera, C.
Hernandez, J.
Xu, R.
Greipp, P. R.
Dispenzieri, A.
Jalal, S. M.
Lacy, M. Q.
Gonzalez-Paz, N.
Gertz, M. A.
San Miguel, J. F.
Fonseca, R.
机构
[1] Hosp Univ Salamanca, Dept Hematol, Salamanca 37007, Spain
[2] Univ Salamanca, Dept Hematol, Ctr Invest Canc, E-37008 Salamanca, Spain
[3] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA
[4] Hosp Virgen Blanca Leon, Dept Hematol, Leon, Spain
[5] Hosp Gen Segovia, Dept Hematol, Segovia, Spain
关键词
DNA deletions; Waldenstrom macroglobulinemia; fluorescence in situ hybridisation; prognostic; 6q deletion;
D O I
10.1111/j.1365-2141.2006.06389.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fluorescence in situ hybridisation (FISH) is an effective technique for the cytogenetic analysis of Waldenstrom macroglobulinemia (WM), but the potential impact of molecular cytogenetics on disease evolution and as a prognostic marker is still unknown. Deletion of the long arm of chromosome 6 (6q-) is the most frequent cytogenetic abnormality in WM. This study analysed the prevalence of this aberration in 102 WM patients, and correlated it with disease characteristics. The incidence of 6q21 deletion was 7% by conventional cytogenetics and 34% when analysed by FISH (54% when cytoplasmic immunoglobulin M-FISH was used). Patients with deletion of 6q displayed features of adverse prognosis, such as higher levels of beta 2-microglobulin and monoclonal paraprotein and a greater tendency to display anaemia and hypoalbuminemia. Interestingly, there was a correlation between the presence of 6q deletion and the International Staging System prognostic index (incidence of 6q- among patients stratified in stages 1, 2 and 3 was 24%, 42% and 67% respectively). Those patients diagnosed with smouldering WM who displayed the abnormality showed a trend to an earlier requirement of treatment. Finally, the survival analysis did not show differences between the two groups of patients, probably due to the short
引用
收藏
页码:80 / 86
页数:7
相关论文
共 50 条
  • [21] 6q deletion is frequent but unrelated to patient prognosis in breast cancer
    Patrick Lebok
    Hannah Bönte
    Martina Kluth
    Christina Möller-Koop
    Isabell Witzel
    Linn Wölber
    Peter Paluchowski
    Christian Wilke
    Uwe Heilenkötter
    Volkmar Müller
    Barbara Schmalfeldt
    Ronald Simon
    Guido Sauter
    Luigi Terracciano
    Rainer Horst Krech
    Albert von der Assen
    Eike Burandt
    Breast Cancer, 2022, 29 : 216 - 223
  • [22] 6q deletion is frequent but unrelated to patient prognosis in breast cancer
    Lebok, Patrick
    Bonte, Hannah
    Kluth, Martina
    Moller-Koop, Christina
    Witzel, Isabell
    Wolber, Linn
    Paluchowski, Peter
    Wilke, Christian
    Heilenkotter, Uwe
    Muller, Volkmar
    Schmalfeldt, Barbara
    Simon, Ronald
    Sauter, Guido
    Terracciano, Luigi
    Krech, Rainer Horst
    von der Assen, Albert
    Burandt, Eike
    BREAST CANCER, 2022, 29 (02) : 216 - 223
  • [23] Impact of Chromosome 6q Deletions in Multiple Myeloma and Waldenstrom's Macroglobulinemia by Next Generation RNA Sequencing
    Guerrera, Maria Luisa
    Jimenez, Cristina
    Chan, Gloria
    Xu, Lian
    Kofides, Amanda
    Demos, Maria
    Tsakmaklis, Nickolas
    Liu, Xia
    Munshi, Manit
    Chen, Jiaji
    Patterson, Christopher
    Tai, Yu-Tzu
    Samur, Mehmet
    Fulciniti, Mariateresa
    Meid, Kirsten
    Keezer, Andrew
    Castillo, Jorge
    Yang, Guang
    Munshi, Nikhil
    Treon, Steven
    Hunter, Zachary
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E39 - E39
  • [24] A deletion in chromosome 6q is associated with human abdominal aortic aneurysm
    Biros, Erik
    Moran, Corey S.
    Walker, Philip J.
    Cardinal, John
    Golledge, Jonathan
    CLINICAL SCIENCE, 2014, 127 (7-8) : 475 - 484
  • [25] Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions
    Schop, RFJ
    Kuehl, WM
    Van Wier, SA
    Ahmann, GJ
    Price-Troska, T
    Bailey, RJ
    Jalal, SM
    Qi, Y
    Kyle, RA
    Greipp, PR
    Fonseca, R
    BLOOD, 2002, 100 (08) : 2996 - 3001
  • [26] Gene Transcriptional Activity Analysis in the 6q Region in Waldenstrom Macroglobulinemia (WM) Using ChIP-on-Chip Technology
    Leleu, Xaiaer
    Hong, Fangxin
    Roccaro, Aldo M.
    Jia, Xiaoying
    Sacco, Antonio
    Moreau, Anne-Sophie
    Ngo, Hai
    Azab, Abdel Kareem
    Azab, Feda
    Melhem, Molly
    Anderson, Kenneth C.
    Ghobrial, Irene M.
    BLOOD, 2008, 112 (11) : 234 - 234
  • [27] Characterization of Chromosome 6q Deletions in MYD88 Mutant and Wild-Type Waldenstrom's Macroglobulinemia
    Guerrera, Maria Luisa
    Tsakmaklis, Nickolas
    Xu, Lian
    Yang, Guang
    Demos, Maria
    Chan, Gloria
    Kofides, Amanda
    Manning, Robert
    Liu, Xia
    Chen, Jiaji
    Patterson, Christopher
    Castillo, Jorge J.
    Dubeau, Toni
    Gustine, Joshua
    Carrasco, Ruben D.
    Arcaini, Luca
    Varettoni, Marzia
    Cazzola, Mario
    Treon, Steven P.
    Hunter, Zachary
    BLOOD, 2017, 130
  • [28] 6q subtelomeric deletion: is there a recognizable syndrome?
    Stevenson, DA
    Brothman, AR
    Carey, JC
    Chen, Z
    Dent, KM
    Bale, JF
    Longo, N
    CLINICAL DYSMORPHOLOGY, 2004, 13 (02) : 103 - 106
  • [29] Analysis of 6q deletion inWaldenstrom macroglobulinernia
    Qi, C.
    Xu, W.
    Reader, J. C.
    Ning, Y.
    Chang, H.
    LABORATORY INVESTIGATION, 2007, 87 : 256A - 256A
  • [30] INTERSTITIAL DELETION 6Q IN A MALFORMED BOY
    NAKAGOME, Y
    TANAKA, T
    HASHIMOTO, T
    KUYAMA, M
    MARUYAMA, M
    ANNALES DE GENETIQUE, 1980, 23 (01): : 49 - 51